10.12
4.12%
0.40
Olema Pharmaceuticals Inc Stock (OLMA) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.90%
34.34
|
30.42 | 23.34 | 21.60 | 29.60 |
Operating Income/Loss |
12.90%
-34.34
|
-30.42 | -23.34 | -21.60 | -29.60 |
Nonoperating Income/Loss |
7.55%
3.369
|
3.644 | 1.84 | 1.506 | 1.316 |
Income/Loss From Continuing Operations Before Tax |
15.69%
-30.97
|
-26.77 | -21.50 | -20.09 | -28.29 |
Income/Loss From Continuing Operations After Tax |
15.68%
-30.97
|
-26.77 | -21.50 | -20.09 | -28.29 |
Net Income/Loss
|
15.68%
-30.97
|
-26.77 | -21.50 | -20.09 | -28.29 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,611%
55.57
|
3.2471 | 44.98 | 40.72 | 40.35 |
Diluted Average Shares |
1,611%
55.57
|
3.2471 | 44.98 | 40.72 | 40.35 |
Basic Earnings Per Share |
16.67%
-0.56
|
-0.48 | -0.48 | -0.49 | -0.70 |
Diluted Earnings Per Share |
16.67%
-0.56
|
-0.48 | -0.48 | -0.49 | -0.69 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):